Sequenom, Inc. (Nasdaq: SQNM) announced that two molecular diagnostic studies using Sequenom's MassARRAY system have concluded successfully. Performed at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE